HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Performance evaluation of a line blot assay system for detection of anti-PM-Scl antibody in Japanese patients with systemic sclerosis.

AbstractOBJECTIVE:
To evaluate the performance of a line blot (LB) assay for identifying anti-PM-Scl antibody (Ab).
METHODS:
We screened 56 serum samples from systemic sclerosis patients using a protein immunoprecipitation (IP) assay and an LB assay (Systemic Sclerosis Profile Euroline® Blot test kit) to detect anti-PM-Scl Ab. We compared the results obtained by the IP and LB assays.
RESULTS:
Among the 56 serum samples of SSc patients, 9 sera were positive for anti-PM-Scl75 Ab and 1 for anti-PM-Scl100 Ab by the LB assay. The protein IP assay revealed that none of the samples precipitated 75 or 100 kDa proteins identical to the anti-PM-Scl Ab reference serum, regardless of the positive or negative results obtained in the LB assay. Therefore, the false-positive rates for both anti-PM-Scl75 Ab and anti-PM-Scl100 Ab by the LB assay were 100%.
CONCLUSION:
Detection of anti-PM-Scl Ab assessed with a commercial LB assay requires extreme caution since it may yield false-positive data.
AuthorsYasuhito Hamaguchi, Masataka Kuwana, Kazuhiko Takehara
JournalInternational journal of rheumatic diseases (Int J Rheum Dis) Vol. 22 Issue 9 Pg. 1746-1751 (Sep 2019) ISSN: 1756-185X [Electronic] England
PMID31245910 (Publication Type: Comparative Study, Evaluation Study, Journal Article)
Copyright© 2019 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.
Chemical References
  • Autoantibodies
  • Biomarkers
  • EXOSC9 protein, human
  • RNA-Binding Proteins
  • Exoribonucleases
  • Exosome Multienzyme Ribonuclease Complex
  • EXOSC10 protein, human
Topics
  • Autoantibodies (blood)
  • Biomarkers (blood)
  • Exoribonucleases (immunology)
  • Exosome Multienzyme Ribonuclease Complex (immunology)
  • False Positive Reactions
  • Humans
  • Immunologic Tests
  • Japan
  • Predictive Value of Tests
  • RNA-Binding Proteins (immunology)
  • Reproducibility of Results
  • Scleroderma, Systemic (blood, diagnosis, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: